Growth Metrics

Soleno Therapeutics (SLNO) EBT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -313.33%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 71.54%
7 Evaxion A 64.16 Bn 64.14 Bn - -79.57%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 9,460.35%
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn 179.76%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 179.76%
Dec 31, 2025 177.77%
Sep 30, 2025 133.95%
Jun 30, 2025 78.46%
Mar 31, 2025 -104.57%
Dec 31, 2024 -373.83%
Sep 30, 2024 -650.55%
Jun 30, 2024 -157.83%
Mar 31, 2024 -156.08%
Dec 31, 2023 -109.73%
Sep 30, 2023 -63.72%
Jun 30, 2023 -25.03%
Mar 31, 2023 -44.74%
Dec 31, 2022 -86.94%
Sep 30, 2022 24.75%
Jun 30, 2022 38.85%
Mar 31, 2022 36.95%
Dec 31, 2021 62.28%
Sep 30, 2021 -5.46%
Jun 30, 2021 0.96%
Mar 31, 2021 1.36%
Dec 31, 2020 -17.85%
Sep 30, 2020 -28.11%
Jun 30, 2020 -99.06%
Mar 31, 2020 -86.46%
Dec 31, 2019 -91.00%
Sep 30, 2019 -58.15%
Jun 30, 2019 -64.75%
Mar 31, 2019 -43.25%
Dec 31, 2018 32.01%
Sep 30, 2018 -47.62%
Jun 30, 2018 -15.11%
Mar 31, 2018 -153.28%
Dec 31, 2017 -183.62%
Sep 30, 2017 -33.49%
Jun 30, 2017 -29.19%
Mar 31, 2017 67.82%
Dec 31, 2016 47.71%
Sep 30, 2016 38.17%
Jun 30, 2016 24.61%
Mar 31, 2016 -75.65%
Dec 31, 2015 15.85%
Sep 30, 2015 -53.40%
Jun 30, 2015 -53.97%
Mar 31, 2015 -126.40%
Dec 31, 2014 -379.25%
Sep 30, 2014 -32.67%